scout
|Videos|July 1, 2020

Expanding Options for Relapsed/Refractory Gastrointestinal Stromal Tumors

Key opinion leaders discuss the evolving treatment paradigm for relapsed/refractory gastrointestinal stromal tumors, and provide an overview of supplemental data presented at the ASCO (American Society of Clinical Oncology) 2020 Annual Meeting.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME